Osmolex ER Parkinson Disease & Drug Induced Extrapyramidal ReactionMethylphenidate ADHDDIVIGEL Moderate to severe Vasomotor Symptoms due to menopause

Syneos / Depomed, Eastern Shore Territory, December 4, 2018 to Present.Promoting Cambia for the treatment of Migraine, Gralise for the management of postherpetic neuralgia ( PHN), and Zipsor for mild to moderate pain to Neurologists and Pain Management.Inventiv Health / Merck Contract, August 8, 2014 to September 29, 2017.Promoting Belsomra for the treatment of insomnia to Neurologists, Psychiatrists, Pulmonologists & Sleep Specialist, Pain Management, and Community Health Centers.34% growth over 13 weeks #1 in a District as of June 2017.Start Strong Finish Strong Year End Award Winner 2016.Pharmaceutical Institute Advance Studies: Field Force - Promotional Communication 3/5/2015, Follow the Dollar - Pharmaceutical and Biotech Finance 3/9/2015, Drug Discovery & Development 3/9/2015,Managed Markets 3/9/2017, Specialty Care Markets 2015, Practical Frameworks for Analysis & Planning 3/20/2015.Pharmaceutical and Biotech Marketing: Intro. to Lifecycle Management 4/10/2015, Ad Agency & Vendor Partnership Part 1 & 2 3/20/2015. Inventiv Health / Shionogi Inc. Contract, May 2012 to August 2014.Pain & Women's Health Sales Executive - Promoted Naprelan for pain to Pain Management, Orhopedic, and Urgent Care. Promoted Osphena for moderate to severe Dyspareunia and Brisdelle for moderate to severe hot flashes to Ob-Gyn.#2 End of Year Ranking for President's Club 2012.Trainer for the IPad roll out which involved test piloting and training of entire Sales Force.Selected by Regional Director for Leadership Development Program "Pursuing Excellence Pilot Team"

Promoted Amrix for pain to pain management groups and orthopedics. Logged hundreds of hours in surgery atending and observing with key targeted physicians.Promoted Nuvigil / Provigil (Wakefulness) to neurologists, psychiatrists, sleep specialists, hospitals, and military treatment facilities.2010 Achievements - Ranked 17 Nationally through May 2010.Exceeded Nation, Region, and District for both products through May 2010.1st quarter Regional Contest Winner for call frequency to super Targets.June 2010 chosen to attend The Associated Professional Sleep Societies Conference in San Antionio, Texas. 1 0f 12 CNS and home office personal invited to attend.Ranking of 49 out of 399 territories through April.Lead District in % to quota and market share growth from March to April 2010.Exceeded National Average 5 week over 5 week growth quarter 1, 2010.2009 Achievements - Overall performance for 2009 was "Superior"2009 Rookie of the Year Award Winner.Overall ranking of 82 out of 390 through August 2009.Finished year with ranking of 100 out of 390, 1 of 5 territories in Top 100 in District, in territory less than 8 months and territory was ranked 323 when I started.Territory was ranked 323 out of 390 in 1st quarter, improved territory ranking to 32 with Amrix from Q1 to Q2.Q3 Performed above the Nation, Region, and Area for Amrix at 104.81% to goal.Launched Nuvigil in June and peformed above the national average with 154% to goal.Compliance rotation corporate headquarters.

Promoted Lunesta for insomnia to Neurologists, Psychiatrist, Sleep Specialists, Primary Care, Hospitals, and Military Treatment Facilities.Promoted Xopenex, Omnaris, and Alvesco for asthma and allergy and Brovana for COPD to Allergy & Asthma, Pediatrics, and Pulmonologists.2008 Achievements - November Ranking of #1 in Region, #5 in Area, #12 in the Nation for launch of new product Alvesco.2008 Ranking to Date All Products is 27 out of 426 territories.2008 168% goal attainment for bonus on #1 ranked product.2007 Achievements - Flight Award Winner 2007 Exceeds Expectations End of Year Review.2006 Achievements Exceeds Expectations End of Year Review.2005 AchievementsExceeds Expectations End of Year Review.2004 Achievements Exceeds Expectations End of Year Review.Territory was ranked 438 in August 2004. I had a major impact on territory with Launch of Lunesta and achieved National Ranking of 33 for the year which resulted in Q1 bonus of $59,000 ( 1 Quarter, not year)!